174 related articles for article (PubMed ID: 21394105)
1. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
[TBL] [Abstract][Full Text] [Related]
2. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
[TBL] [Abstract][Full Text] [Related]
3. Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.
Fuchita M; Ardiani A; Zhao L; Serve K; Stoddard BL; Black ME
Cancer Res; 2009 Jun; 69(11):4791-9. PubMed ID: 19487291
[TBL] [Abstract][Full Text] [Related]
4. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.
Graepler F; Lemken ML; Wybranietz WA; Schmidt U; Smirnow I; Gross CD; Spiegel M; Schenk A; Graf H; Lauer UA; Vonthein R; Gregor M; Armeanu S; Bitzer M; Lauer UM
World J Gastroenterol; 2005 Nov; 11(44):6910-9. PubMed ID: 16437592
[TBL] [Abstract][Full Text] [Related]
6. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
7. Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.
Christensen CL; Gjetting T; Poulsen TT; Cramer F; Roth JA; Poulsen HS
Clin Cancer Res; 2010 Apr; 16(8):2308-19. PubMed ID: 20371678
[TBL] [Abstract][Full Text] [Related]
8. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
[TBL] [Abstract][Full Text] [Related]
9. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
[TBL] [Abstract][Full Text] [Related]
10. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
11. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.
Kievit E; Bershad E; Ng E; Sethna P; Dev I; Lawrence TS; Rehemtulla A
Cancer Res; 1999 Apr; 59(7):1417-21. PubMed ID: 10197605
[TBL] [Abstract][Full Text] [Related]
12. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
13. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
14. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.
Nyati MK; Symon Z; Kievit E; Dornfeld KJ; Rynkiewicz SD; Ross BD; Rehemtulla A; Lawrence TS
Gene Ther; 2002 Jul; 9(13):844-9. PubMed ID: 12080378
[TBL] [Abstract][Full Text] [Related]
15. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.
Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M
Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724
[TBL] [Abstract][Full Text] [Related]
16. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
17. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
Nouri FS; Wang X; Hatefi A
J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein.
Lears KA; Parry JJ; Andrews R; Nguyen K; Wadas TJ; Rogers BE
Cancer Gene Ther; 2015 Mar; 22(4):215-21. PubMed ID: 25837665
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]